跳至主要内容
临床试验/ISRCTN70051203
ISRCTN70051203已完成3 期

Seizure PRophylaxis IN Glioma (SPRING): a Phase III randomised trial comparing prophylactic levetiracetam versus no prophylactic antiepileptic drug in patients with newly diagnosed presumed supratentorial glioma

Public Health Scotland0 个研究点目标入组 107 人开始时间: 2019年7月2日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
107

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with suspected cerebral glioma on MRI or CT
  • 2. Capable of giving informed consent
  • 3. Patients must be =16 years old
  • 4. Patients must have a Karnofsky performance status of >60
  • 5. Patients must be able to safely swallow pills
  • 6. Planned surgery for presumed glioma (biopsy or resection)
  • Capable of giving informed consent

排除标准

  • 1. Pregnant
  • 2. History of any type of seizure for at least 10 years prior to randomisation
  • 3. Known Severe Chronic Kidney Disease (CKD4 - eGRR <30 ml/min)
  • 4. Concomitant methotrexate
  • 5. Concomitant Anti-Epileptic Drug (including use for other reasons (e.g. pain))
  • 6. Concomitant Benzodiazepines
  • 7. Hypersensitivity to Levetiracetam

研究者

发起方
Public Health Scotland

相似试验

Does giving an anti-epileptic drug before surgery... | 临床试验